Title:
抗癌剤
Document Type and Number:
Japanese Patent JP6886278
Kind Code:
B2
Abstract:
PROBLEM TO BE SOLVED: To provide new cancer preventive and therapeutic agents.SOLUTION: An anticancer agent has a combination of an immune checkpoint inhibitor and an HMG-CoA reductase inhibitor.SELECTED DRAWING: None
Inventors:
Kinya Tsubota
Tomonori Taniguchi
Sakiko Nishio
Yutaka Kawakami
Tomonori Taniguchi
Sakiko Nishio
Yutaka Kawakami
Application Number:
JP2016234473A
Publication Date:
June 16, 2021
Filing Date:
December 01, 2016
Export Citation:
Assignee:
Keio University
Kowa Co., Ltd.
Kowa Co., Ltd.
International Classes:
A61K39/395; A61K31/47; A61P35/00; A61P43/00
Domestic Patent References:
| JP2011246432A |
Foreign References:
| WO2016130889A1 | ||||
| WO2016131380A1 |
Other References:
SORRENTINO, G. et al.,Nat Cell Biol,2014年,Vol. 16, No.4,pp. 357-366
ZHOU, T.Y. et al,Sci Rep,2016年 8月,Vol. 6, Article No. 30483,pp. 1-12
MIETTINEN, T.P. et al.,Cell Rep,2015年,Vol. 13,pp. 2610-2620
ZHOU, T.Y. et al,Sci Rep,2016年 8月,Vol. 6, Article No. 30483,pp. 1-12
MIETTINEN, T.P. et al.,Cell Rep,2015年,Vol. 13,pp. 2610-2620
Attorney, Agent or Firm:
Alga Patent Office, a patent business corporation
Toshio Takano
Toshio Nakajima
Masaki Murata
Hiroto Yamamoto
Toshio Takano
Toshio Nakajima
Masaki Murata
Hiroto Yamamoto